Free tool
Dividend paying stocks
We cover 28 companies that currently pay a dividend. The median market value in the group is $14.73B. Across the group, the median move over the past trading day is −0.03%. 67% of the 27 with a 200-day average trade above it. Price change over the past year runs from −21.5% to +39.5% across the middle 80 percent of the group, with a median of +3.9%.
Other lists in this group
Table
28 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% | Oct 14, 2026 |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% | Oct 20, 2026 |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% | Oct 20, 2026 |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% | Oct 23, 2026 |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% | Oct 21, 2026 |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% | Oct 21, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% | Oct 22, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% | Oct 22, 2026 |
| SIG.AX | Sigma Healthcare Limited | $21.65B | Large cap | −15.21% | Aug 27, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% | Oct 22, 2026 |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% | Oct 26, 2026 |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% | Oct 26, 2026 |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% | Oct 22, 2026 |
| RHC.AX | Ramsay Health Care Limited | $8.27B | Mid cap | +50.11% | Aug 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% | Aug 27, 2026 |
| 3349.T | COSMOS Pharmaceutical Corporation | $3.26B | Mid cap | −26.59% | Oct 13, 2026 |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% | Sep 17, 2026 |
| 7649.T | Sugi Holdings Co.,Ltd. | $3.13B | Mid cap | −28.60% | Oct 8, 2026 |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | $2.44B | Mid cap | +5.23% | Oct 1, 2026 |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% | Aug 27, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.